Observational studyDiabetes, obesity & metabolism2022

The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Patients with Type 2 Diabetes (TROPHIES): Patient disposition, clinical characteristics and treatment persistence at 12 months.

Bruno Guerci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.